Stay updated on Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial

Sign up to get notified when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Version bumped from v3.0.0 to v3.0.1 and a Back to Top control was added; this is a minor patch and UX enhancement with no substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-09T21:32:55.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the removal of numerous principal investigator contact details and the addition of new dates for updates. The revision number has also been updated.
    Difference
    19%
    Check dated 2025-08-12T05:21:54.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page has updated its contact information for two principal investigators, Clay M. Hoerig and Rebecca J. Deyell, and has revised the last update date and version number.
    Difference
    0.6%
    Check dated 2025-08-05T01:42:32.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The page has been updated to reflect new contact information for the Principal Investigator, Elizabeth A. Raetz, and the addition of the HHS Vulnerability Disclosure. Additionally, the last update date has changed to July 28, 2025, and the revision number has been updated to v2.16.8.
    Difference
    1%
    Check dated 2025-07-29T00:12:23.000Z thumbnail image
  8. Check
    56 days ago
    Change Detected
    Summary
    The webpage has updated its contact information and added new recruitment details, including new principal investigators and their contact numbers, while removing outdated contacts.
    Difference
    0.7%
    Check dated 2025-07-21T20:56:42.000Z thumbnail image
  9. Check
    63 days ago
    Change Detected
    Summary
    The web page has updated its contact information, replacing the previous principal investigator Joel A. Kaplan with Stephanie M. Villeneuve, and has introduced a service alert regarding planned maintenance starting July 25th.
    Difference
    1.0%
    Check dated 2025-07-14T15:16:50.000Z thumbnail image

Stay in the know with updates to Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.